HeartFlow
NASDAQ: HTFLRedwood City, US · Delaware corporation · 8 known investors
Heartflow develops AI-powered 3D modeling and diagnostic tools for coronary artery disease detection and management, serving clinicians and healthcare teams to optimize patient care pathways.
Founders & leadership
LS
Lonnie SmithDirector
CK
Christopher K. ZarinsExecutive Officer, Director
CT
Casey TanseyDirector
TH
Tom HawesDirector
JL
Jeff LightcapDirector
BU
Barry UphoffDirector
CA
Charles A. TaylorExecutive Officer, Director
NE
Nicky Espinosa HayesExecutive Officer
WW
William WeldonDirector
JS
John StevensExecutive Officer, Director
HB
H. Baird Radford, IIIExecutive Officer
PM
Philip M. YoungDirector
Investors · 8
Bain Capital Life SciencesBoston
Blue Venture FundsChicago · $1M – $20M
Emergent Medical Partners, LLPSan Jose
Khosla VenturesMenlo Park · $5K – $50M
Lifeforce CapitalChevy Chase · $500K – $5M
Lotus CapitalCupertino
Silver Lake PartnersMenlo Park
US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Reported raises · per SEC filings
Form D private placements▶$65MraisedJun 2019 · 9 investors · BiotechnologyRule 506(b)
▶$65MraisedJun 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dana MeadExecutive Officer, Director
- Charles A. TaylorExecutive Officer, Director
- John StevensDirector
- Casey TanseyDirector
- Lonnie SmithDirector
- William WeldonDirector
- Kent WalkerDirector
- H. Baird Radford, IIIExecutive Officer
- Noemi C. EspinosaExecutive Officer
- Jeff LightcapDirector
- Offering amount
- $100M
- Amount sold
- $65M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$90MraisedDec 2017 · 2 investors · BiotechnologyRule 506(b)
▶$90MraisedDec 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- KENT WALKERDirector
- CHARLES A. TAYLORExecutive Officer, Director
- JEFF LIGHTCAPDirector
- TOM HAWESDirector
- JOHN STEVENSExecutive Officer, Director
- LONNIE SMITHDirector
- BARRY UPHOFFDirector
- NOEMI C. ESPINOZAExecutive Officer
- CASEY TANSEYDirector
- H. BAIRD RADFORD, IIIExecutive Officer
- PHILIP M. YOUNGDirector
- CHRISTOPHER K. ZARINSExecutive Officer, Director
- WILLIAM WELDONDirector
- Offering amount
- $150M
- Amount sold
- $90M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$99.9MraisedMay 2016 · 25 investors · BiotechnologyRule 506(b)
▶$99.9MraisedMay 2016 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lonnie SmithDirector
- Christopher K. ZarinsExecutive Officer, Director
- Casey TanseyDirector
- Tom HawesDirector
- Jeff LightcapDirector
- Barry UphoffDirector
- Charles A. TaylorExecutive Officer, Director
- Nicky Espinosa HayesExecutive Officer
- William WeldonDirector
- John StevensExecutive Officer, Director
- H. Baird Radford, IIIExecutive Officer
- Philip M. YoungDirector
- Kent WalkerDirector
- Offering amount
- $110.9M
- Amount sold
- $99.9M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.